Semalytix's mission is to improve patient-centricity, inform patient engagement, and provide insights for developing more patient-focused drugs and therapies.
Semalytix is a Germany-based AI startup that has developed PatientGPTTM and PharosTM. Both are AI-powered patient-centricity solutions. They amplify the global patient voice, making it easier and more scalable to identify unmet patient needs and to gain a deeper understanding of how people genuinely experience diseases.
Semalytix's expertise in artificial intelligence, natural language processing, and Large-Language Models enables them to comprehensively anonymise and accurately analyze vast amounts of real-world patient experience data in over 25 languages. This unique approach positions Semalytix at the forefront of aiding pharmaceutical companies in designing patient-centric
strategies, improving patient engagement and advancing patient-focused drug development.
The company is focused on establishing new, scalable, and reliable solutions that improve patient understanding for a simple reason, patient-centricity will only be achieved and maintained over time if complexity, cost, and the time needed to create insights, identify unmet needs, and even craft entire, patient experience data-based patient journeys are dramatically
reduced.
Website: https://semalytix.com/
